Cargando…

Pheochromocytoma and Neurofibromatosis Type 1 in a Patient with Hypertension

BACKGROUND: Neurofibromatosis type 1 is an autosomal dominant condition that has a variety of clinical manifestations. Essential or secondary hypertension may be associated with neurofibromatosis. A rare finding is hypertension due to pheochromocytoma in patient with neurofibromatosis type 1. CASE R...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrovska, Julijana, Kitanovska, Biljana Gerasimovska, Bogdanovska, Stevka, Kuzmanoska, Svetlana Pavleska
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Institute of Immunobiology and Human Genetics 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877914/
https://www.ncbi.nlm.nih.gov/pubmed/27275314
http://dx.doi.org/10.3889/oamjms.2015.130
_version_ 1782433476541153280
author Petrovska, Julijana
Kitanovska, Biljana Gerasimovska
Bogdanovska, Stevka
Kuzmanoska, Svetlana Pavleska
author_facet Petrovska, Julijana
Kitanovska, Biljana Gerasimovska
Bogdanovska, Stevka
Kuzmanoska, Svetlana Pavleska
author_sort Petrovska, Julijana
collection PubMed
description BACKGROUND: Neurofibromatosis type 1 is an autosomal dominant condition that has a variety of clinical manifestations. Essential or secondary hypertension may be associated with neurofibromatosis. A rare finding is hypertension due to pheochromocytoma in patient with neurofibromatosis type 1. CASE REPORT: We present a case with a 7-year medical history of hypertension which was poorly controlled and with wide variations of blood pressure before the examination. Investigations did not reveal a secondary cause of hypertension. After the physical examination and establishing the diagnosis of neurofibromatosis, as well as the history of symptomes suggestive of catecholamine discharge, diagnostic procedures for pheochromocytoma were undertaken. Abdominal CT and MRI have proven the presence of a right adrenal tumor mass which was suspected to be a pheochromocytoma. Patient was preoperatively treated for two weeks with alpha and beta blokers and right adrenalectomy was performed. Perioperatively and on a longer term, blood pressure remained well controlled with less antihypertensive therapy. Diagnosis and management of pheochromocytoma in neurofibromatosis involves a dermatologist, endocrinologist, nephrologist and an urologist and requires a well-coordinated multidisciplinary approach. CONCLUSIONS: Pheochromocytoma, although a rare condition in patients with neurofibromatosis, may be a cause for uncontrolled hypertension, as well as other cardiovascular complications and the clinician should do all available clinical investigations to confirm it or exclude it on time.
format Online
Article
Text
id pubmed-4877914
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Institute of Immunobiology and Human Genetics
record_format MEDLINE/PubMed
spelling pubmed-48779142016-06-06 Pheochromocytoma and Neurofibromatosis Type 1 in a Patient with Hypertension Petrovska, Julijana Kitanovska, Biljana Gerasimovska Bogdanovska, Stevka Kuzmanoska, Svetlana Pavleska Open Access Maced J Med Sci Case Report BACKGROUND: Neurofibromatosis type 1 is an autosomal dominant condition that has a variety of clinical manifestations. Essential or secondary hypertension may be associated with neurofibromatosis. A rare finding is hypertension due to pheochromocytoma in patient with neurofibromatosis type 1. CASE REPORT: We present a case with a 7-year medical history of hypertension which was poorly controlled and with wide variations of blood pressure before the examination. Investigations did not reveal a secondary cause of hypertension. After the physical examination and establishing the diagnosis of neurofibromatosis, as well as the history of symptomes suggestive of catecholamine discharge, diagnostic procedures for pheochromocytoma were undertaken. Abdominal CT and MRI have proven the presence of a right adrenal tumor mass which was suspected to be a pheochromocytoma. Patient was preoperatively treated for two weeks with alpha and beta blokers and right adrenalectomy was performed. Perioperatively and on a longer term, blood pressure remained well controlled with less antihypertensive therapy. Diagnosis and management of pheochromocytoma in neurofibromatosis involves a dermatologist, endocrinologist, nephrologist and an urologist and requires a well-coordinated multidisciplinary approach. CONCLUSIONS: Pheochromocytoma, although a rare condition in patients with neurofibromatosis, may be a cause for uncontrolled hypertension, as well as other cardiovascular complications and the clinician should do all available clinical investigations to confirm it or exclude it on time. Institute of Immunobiology and Human Genetics 2015-12-15 2015-12-06 /pmc/articles/PMC4877914/ /pubmed/27275314 http://dx.doi.org/10.3889/oamjms.2015.130 Text en Copyright: © 2015 Julijana Petrovska, Biljana Gerasimovska Kitanovska, Stevka Bogdanovska, Svetlana Pavleska Kuzmanoska. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Case Report
Petrovska, Julijana
Kitanovska, Biljana Gerasimovska
Bogdanovska, Stevka
Kuzmanoska, Svetlana Pavleska
Pheochromocytoma and Neurofibromatosis Type 1 in a Patient with Hypertension
title Pheochromocytoma and Neurofibromatosis Type 1 in a Patient with Hypertension
title_full Pheochromocytoma and Neurofibromatosis Type 1 in a Patient with Hypertension
title_fullStr Pheochromocytoma and Neurofibromatosis Type 1 in a Patient with Hypertension
title_full_unstemmed Pheochromocytoma and Neurofibromatosis Type 1 in a Patient with Hypertension
title_short Pheochromocytoma and Neurofibromatosis Type 1 in a Patient with Hypertension
title_sort pheochromocytoma and neurofibromatosis type 1 in a patient with hypertension
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877914/
https://www.ncbi.nlm.nih.gov/pubmed/27275314
http://dx.doi.org/10.3889/oamjms.2015.130
work_keys_str_mv AT petrovskajulijana pheochromocytomaandneurofibromatosistype1inapatientwithhypertension
AT kitanovskabiljanagerasimovska pheochromocytomaandneurofibromatosistype1inapatientwithhypertension
AT bogdanovskastevka pheochromocytomaandneurofibromatosistype1inapatientwithhypertension
AT kuzmanoskasvetlanapavleska pheochromocytomaandneurofibromatosistype1inapatientwithhypertension